Related Experiment Videos
A minimum age for measles vaccine administration to coloured children
Insights
Measles vaccination in infants aged 6-12 months showed lower antibody response in those under 9 months. Routine measles vaccine administration is recommended for children over 8 months old.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Measles remains a significant public health concern globally.
- Early infant vaccination is crucial for disease prevention.
- Understanding optimal timing for measles vaccine administration is vital.
Purpose of the Study:
- To assess the antibody response to measles vaccine in infants.
- To determine the optimal age for routine measles vaccination.
- To identify factors affecting vaccine efficacy in young children.
Main Methods:
- Studied 67 children aged 6-12 months.
- Administered a further-attenuated live virus measles vaccine.
- Assessed seroconversion rates to evaluate antibody response.
Main Results:
- Infants under 9 months exhibited suboptimal seroconversion rates.
- Children aged 9 months and older showed better antibody response.
- Vaccine administration and storage challenges were noted.
Conclusions:
- Routine measles vaccination should be administered to children over 8 months of age.
- Age is a critical factor for achieving adequate antibody response.
- Further consideration of high-risk groups and logistical issues is necessary.
Abstract:
The antibody response to further-attenuated live virus measles vaccine was assessed in 67 Coloured children between the ages of 6 and 12 months. Children less than 9 months of age were found to have suboptimal seroconversion rates and it is recommended that the routine administration of measles vaccine should be restricted to children over the age of 8 months. High-risk groups and problems of vaccine administration and storage are discussed.